Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Halozyme, a San Diego-based drugmaker, will cut its workforce by 55 percent after its lead drug failed in a clinical trial, according to STAT.

Fagron is recalling all unexpired lots of its topical anesthesia that was distributed nationwide to hospitals, pharmacies and distributors after the FDA found possible bacterial contamination.

After months of testing common heartburn drugs, the FDA said Nov. 1 that the levels of a cancer-causing substance in ranitidine products that prompted several recalls was no higher than what is found in common foods like grilled or smoked…

A Mississippi pharmacy owner was sentenced Oct. 31 to 10 years in prison for defrauding Tricare of $243 million, according to Fox Business.

Hospitals nationwide are facing shortages of crucial, lifesaving drugs, with 116 drugs currently running low, according to the FDA and cited by NBC News.  

For the second year in a row, hospital and health system CEOs ranked cost containment as one of their top three strategic priorities, according to the Advisory Board Annual Health Care CEO survey. The survey also found that c-suite executives…

President Donald Trump said Nov. 1 that he will nominate Stephen Hahn, MD, and CMO of MD Anderson Cancer Center in Houston, to lead the FDA, according to STAT.

Drug Topics compiled a list of the 10 worst states to live and work as a pharmacist by compiling data from the Bureau of Labor Statistics, WalletHub and U.S. News and World Report.

A proposal to encourage drugmakers to develop new antibiotics by offering market exclusivity vouchers could cost an additional $4.5 billion in public and private drug spending, according to a study published Oct. 20 in Oxford Academic.